"the Company has signed a non-binding term-sheet on June 16, 2020 with China Health Industries Holdings, Inc. (CHHE) where CHHE intends to purchase up to $12 million of BRQS ordinary shares at the market price and warrants which have a two-year term and are exercisable at a premium of 25% above the sales price of the ordinary shares."
"The transaction is subject to the signing of definitive documents within the next several weeks"
Ma sono nuove azioni che vengono messe in circolazione o azioni già esistenti? Sarei più per la prima ipotesi ma allora il prezzo dell'azione avrebbe dovuto risentirne